Literature DB >> 15297280

Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order.

A Wanders1, R Landewé, A Spoorenberg, K de Vlam, H Mielants, M Dougados, S van der Linden, D van der Heijde.   

Abstract

OBJECTIVES: To describe the influence of the reading order (chronological v paired) on radiographic scoring results in ankylosing spondylitis. To investigate whether this method is sufficiently sensitive to change because paired reading is requested for establishing drug efficacy in clinical trials.
METHODS: Films obtained from 166 patients (at baseline, 1 year, and 2 years) were scored by one observer, using the modified Stoke Ankylosing Spondylitis Spinal Score. Films were first scored chronologically, and were scored paired 6 months later.
RESULTS: Chronological reading showed significantly more progression than paired reading both at 1 year (mean (SD) progression 1.3 (2.6) v 0.5 (2.4) units) and at 2 years (2.1 (3.9) v 1.0 (2.9) units); between-method difference: p<0.001 at 1 year, and p<0.001 at 2 years. After 1 year, progression (>0 units) was found in 35/166 (21%) patients after paired reading and in 55/166 (33%) after chronological reading. After 2 years, these figures were 50/166 (30%) and 68/166 (41%), respectively. Sample size calculations showed that 94 patients in each treatment arm are required in a randomised clinical trial (RCT) to provide sufficient statistical power to detect a difference in 2 year progression if films are scored paired.
CONCLUSION: Reading with chronological time order is more sensitive to change than reading with paired time order, but paired reading is sufficiently sensitive to pick up change with a follow up of 2 years, resulting in an acceptable sample size for RCTs.

Entities:  

Mesh:

Year:  2004        PMID: 15297280      PMCID: PMC1754835          DOI: 10.1136/ard.2004.022038

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials.

Authors:  D van Der Heijde; A Boonen; M Boers; P Kostense; S van Der Linden
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

2.  Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.

Authors:  D van der Heijde; S van der Linden; N Bellamy; A Calin; M Dougados; M A Khan
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

3.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

4.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

5.  Radiographic progression depicted by probability plots: presenting data with optimal use of individual values.

Authors:  Robert Landewé; Désirée van der Heijde
Journal:  Arthritis Rheum       Date:  2004-03

6.  Interobserver variation in quantitative analysis of hand radiographs in rheumatoid arthritis: comparison of 3 different reading procedures.

Authors:  F Salaffi; M Carotti
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

7.  Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence.

Authors:  Karin Bruynesteyn; Désirée Van Der Heijde; Maarten Boers; Ariane Saudan; Paul Peloso; Harold Paulus; Harry Houben; Bridget Griffiths; John Edmonds; Barry Bresnihan; Annelies Boonen; Sjef Van Der Linden
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

8.  Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide.

Authors:  R Ferrara; F Priolo; M Cammisa; L Bacarini; A Cerase; G Pasero; G F Ferraccioli; O D Alberighi; A Antonellini; E Marubini
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

9.  What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter.

Authors:  Astrid J B Wanders; Robert B M Landewé; Anneke Spoorenberg; Maxime Dougados; Sjef van der Linden; Herman Mielants; Hille van der Tempel; Désirée M F M van der Heijde
Journal:  Arthritis Rheum       Date:  2004-08

10.  Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years.

Authors:  Anneke Spoorenberg; Kurt de Vlam; Sjef van der Linden; Maxime Dougados; Herman Mielants; Hille van de Tempel; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

  10 in total
  20 in total

1.  [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Authors:  J Braun; J Zochling; E Märker-Hermann; G Stucki; H Böhm; M Rudwaleit; H Zeidler; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 2.  [Imaging in ankylosing spondylitis].

Authors:  J Braun; M Rudwaleit; K G Hermann; R Rau
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

3.  Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: a longitudinal study.

Authors:  Tae-Han Lee; Bon San Koo; Bora Nam; Yun Jin Kim; Donghee Son; Seunghun Lee; Kyung Bin Joo; Tae-Hwan Kim
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-23       Impact factor: 3.625

4.  Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis.

Authors:  Bedriye Mermerci Başkan; Filiz Sivas; Esra Erkol Inal; Semra Duran; Eda Elverici; Kürşat Ozoran; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2009-10-08       Impact factor: 2.980

5.  Machine learning-based prediction of radiographic progression in patients with axial spondyloarthritis.

Authors:  Young Bin Joo; In-Woon Baek; Yune-Jung Park; Kyung-Su Park; Ki-Jo Kim
Journal:  Clin Rheumatol       Date:  2019-10-30       Impact factor: 2.980

6.  Genetic analysis of TNFST15 variants in ankylosing spondylitis.

Authors:  Nai-Guo Wang; Feng Wang; Bing-Yi Tan; Shi-Jie Han; Jun Dong; Ze-Nong Yuan; Da-Chuan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  Diagnosis and progression of sacroiliitis in repeated sacroiliac joint computed tomography.

Authors:  Mats Geijer; Gro Gadeholt Göthlin; Jan H Göthlin
Journal:  Arthritis       Date:  2013-09-03

Review 8.  Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.

Authors:  Runsheng Wang; Joan M Bathon; Michael M Ward
Journal:  Arthritis Rheumatol       Date:  2020-02-24       Impact factor: 15.483

9.  Analysis of PPARGC1B, RUNX3 and TBKBP1 polymorphisms in Chinese Han patients with ankylosing spondylitis: a case-control study.

Authors:  Zijian Lian; Wei Chai; Lewis L Shi; Chao Chen; Jingyi Liu; Yan Wang
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

10.  Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Authors:  Sofia Ramiro; Astrid van Tubergen; Carmen Stolwijk; Robert Landewé; Filip van de Bosch; Maxime Dougados; Désirée van der Heijde
Journal:  Arthritis Res Ther       Date:  2013-01-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.